- Home
- MDGL vs AXS Comparison
MDGL vs AXS Comparison
Compare MDGL & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- AXS
- Stock Information
- Founded
- MDGL 2011
- AXS 2001
- Country
- MDGL United States
- AXS Bermuda
- Employees
- MDGL N/A
- AXS N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- AXS Property-Casualty Insurers
- Sector
- MDGL Health Care
- AXS Finance
- Exchange
- MDGL Nasdaq
- AXS Nasdaq
- Market Cap
- MDGL 7.4B
- AXS 7.6B
- IPO Year
- MDGL N/A
- AXS N/A
- Fundamental
- Price
- MDGL $308.44
- AXS $90.06
- Analyst Decision
- MDGL Buy
- AXS Strong Buy
- Analyst Count
- MDGL 14
- AXS 7
- Target Price
- MDGL $347.33
- AXS $98.71
- AVG Volume (30 Days)
- MDGL 355.8K
- AXS 658.9K
- Earning Date
- MDGL 10-31-2024
- AXS 01-29-2025
- Dividend Yield
- MDGL N/A
- AXS 1.96%
- EPS Growth
- MDGL N/A
- AXS 15.01
- EPS
- MDGL N/A
- AXS 7.19
- Revenue
- MDGL $76,813,000.00
- AXS $5,967,185,000.00
- Revenue This Year
- MDGL N/A
- AXS N/A
- Revenue Next Year
- MDGL $194.49
- AXS $7.16
- P/E Ratio
- MDGL N/A
- AXS $12.52
- Revenue Growth
- MDGL N/A
- AXS 6.37
- 52 Week Low
- MDGL $168.25
- AXS $53.88
- 52 Week High
- MDGL $368.29
- AXS $94.89
- Technical
- Relative Strength Index (RSI)
- MDGL 51.11
- AXS 52.37
- Support Level
- MDGL $289.80
- AXS $88.34
- Resistance Level
- MDGL $315.09
- AXS $94.89
- Average True Range (ATR)
- MDGL 12.44
- AXS 2.30
- MACD
- MDGL -4.11
- AXS -0.71
- Stochastic Oscillator
- MDGL 48.58
- AXS 41.60
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a property and casualty insurance company that provides various products and services to clients and distribution partners. The company has operating subsidiaries and branch networks based in Bermuda, the United States, Canada, Europe, and Singapore. Its business consists of two distinct global underwriting platforms, AXIS Insurance, and AXIS Reinsurance. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks.